- -

' , , " -
 
  1. : SV40 .
  2. SV40 .
  3. .
' , , " -
 
  1. .
  2. .
  3. .
  4. .
  5. .
  6. .
' , ( ), " -
 
  1. -.
  2. .
  3. .
  4. ( Tolerance ).
  5. (Signal transduction) B -.
' ,
 
  1. .
  2. " RNA .
' - , ,
 
  1. .
  2. .
  3. .
  4. "-":
    1. -.
    2. .
' -,
 
  1. .
  2. .
  3. , .
  4. - , .
  5. .
' -, ,
 
  1. 2.
  2. .
" , ,
 
  1. , , .
  2. : , , , , .
' , ,
 
  1. , .
  2. .
' , , " -
 
  1. .
  2. .
  3. .
  4. .
' , , " -
 
  1. What are the structural and effector mechanisms involved in pathogen- ediated modulation of inflammatory autoimmune diseases ?
  2. Which molecules are involved in inflammatory lesion formation in the central nervous system and other target organs during the course of autoimmunity.
  3. immunologic . Are the pathogenetic cocepts evolving from animal experiments, pathologic and studies a basis for the desing of new immunotherapeutic modalities in autoimmune diseases?
' , , ,
 
  1. .
  2. .
' , ,
 
  1. .
  2. ( , , ).
' , , " -
 
  1. Liposomes - Formulation (and in Vivo Biodistribution) Aspects.
  2. Liposomes as carriers of drugs and other agents for medical applications.
' , ' - , "
  1. .
  2. .
  3. .
  4. : , , '.
' , ' ,
 
  1. .
  2. ( ' ).
  3. Rhizopus oryzae.
  4. Paraccocus marcusli ( ' ).
' , , "
 
  1. - .
  2. .
  3. .
" , ,
 
  1. -.
  2. . .
' , , " -
 
' , ,
 
  1. .
  2. " .
  3. , .
' -' ' , ,
 
  1. DNA , .
  2. , " - PCR .
  3. DNA-- " .
' , ' - , "
 
  1. Gene Therapy- polymeric systems for gene transfer in vitro/vivo.
  2. Tissue engineering-design of sufolds for cell growth.
  3. Biopolymers for controlled drug delivery .
" - , , " -
 

The influence of aging estrogens and phyoestrogenes on endothelial function and vascular reactivity in an ex-vivo rat aorta model.

' , ,
 
  1. siRNA .
  2. CREB .
  3. .
  4. (CMV) . ( " ).
' , , " -
 
  1. ( ) .
  2. .
  3. ( ) .
' , ,
 
  1. .
  2. .
  3. ( " ).
' -, ,
 
  1. - .
  2. T.
' , ,
 
  1. : .
  2. " .
' , , "
 
  1. .
  2. .
  3. .
  4. ().
  5. .
  6. .
' , ,
 
  1. - . -.
  2. -.
' , ,
 
  1. "" ; ( , , ).
  2. - .
  3. " .
' ,
 
  1. .
  2. oct-1 B.
  3. BCLG B .
' -, , "
  .
" , , -
 
  1. " , GSF/PDX .
  2. - GSF/PDX .
  3. " ".
  4. .
    1. .
    2. B.
" , ,
 



" , ,
  . - - . . . .
' , ,
 
  1. .
  2. .
  3. .
  4. () .
' , - -
 
  1. (PTH), .
  2. - PTH mRNA - mRNA " RNA .
  3. - PTH mRNA :
    1. .
    2. PTH .
' ' , , " -.
 
  1. (Parathyraid hormone)
  2. .
' ', , " -
 
  1. .
  2. .
  3. .
' , , " -
 
  1. - ( ex-vivo expansion ) - .
  2. - .
  3. .
  4. .
' , ,
 
  1. .
  2. .
  3. .
  4. ( ' . ).
' , ,
 
  1. .
  2. HIV.
' , , "
  .
' , , " -
Molecular engineering of recombinant MHC-Class I peptid construct.
' , , " -
 
  1. .
  2. .
  3. vif, vpu,vpr - HIV.
' , ,
 
  1. -.
  2. , , .
' , ,
  1. RNA .
  2. RNA - mRNA .
  3. " .
  4. .
' , , ,
  .
' , ,
 
  1. .
  2. .
  3. .
' , ' ,
 
  1. .
  2. .
  3. .
  4. " .
, ' ,
 
  1. Strepromyces.
  2. .
' , ,
 
  1. .
  2. " .

' , ,
 
  1. DNA Methylation and Gene Eexpression.
  2. Regional Control of Imprinted Genes.
  3. DNA Metylation in Genetic Diseases.
' , , " -
 
  1. T .
  2. T ? " PP14.
  3. , PP14 .
" , ,
 
  1. C-JUN , .
  2. - TUMOR SUPRESSORS TUMOR SUPRESSORS.
  3. JNK C-JUN.
' , ,
 
  1. .
  2. .
  3. .
  4. ( . . , ).
' , , " -
 
  1. B EBV .
  2. .
  3. .
  4. .



| - | | | | | | | |
| - | . | | | | |